SHIKARI® Q-GOL


Enzyme immunoassay for the quantitative determination of free Golimumab (Simponi®) in serum and plasma.

The Matriks Biotek Shikari Golimumab ELISA has been especially developed for the quantitative analysis of free Golimumab in serum and plasma samples.



Click the diagram to see bigger

about-me





Required Volume (µl) 10
Total Time (min) 70
Sample Serum, plazma and other biological fluids
Sample Number 96
Dedection Limit (mg/mL) 0,1
Spike Recovery (%) 93
Shelf Life (year) 1

SHIKARI® S-ATG


Enzyme immunoassay for the qualitative determination of antibodies to Golimumab in serum and plasma.

Golimumab (Simponi®) was associated to the development of anti- Golimumab antibodies, even some were reported to be neutralizing, in various percentages of patients during therapy with the drug Simponi®. This might lead to severe complications. The Matriks Biotek shikari® Antibody to Golimumab ELISA Kit can be efficiently used for monitoring anti-Golimumab antibodies during therapy and offers the clinician a tool for decision on possible preventive measures such as possible addition of immunosuppressive drug to reduce anti-Golimumab antibodies.





Required Volume (µl) 10
Total Time (min) 140
Sample Serum, plasma
Sample Number 96
Dedection Limit (ng/mL) + / -
Spike Recovery (%) -
Shelf Life (year) 1

MATRIKS BIOTECHNOLOGY CO., LTD

Gazi Üniversitesi Gölbaşı Yerleşkesi Teknoplaza Binası,
(B Blok Zemin Kat BZ17),
06830,
Gölbaşı/ANKARA/TÜRKİYE

Contact Details

Telephone: +90 (312) 485 42 94
Email: info@matriksbiotek.com
Fax: +90 (312) 485 11 87